Sfoglia per Autore
Systolic blood pressure target less than 120 mmHg. the 'Chariot Allegory' in hypertension?
2020 Gallo, Giovanna; Volpe, Massimo
A plea for smoking-free policies in COVID-19 times: cardiovascular prevention as an ally in coronavirus containment
2021 Tini, G.; Gallo, G.; Musumeci, B.; Tocci, G.; Volpe, M.
Cardiopulmonary exercise testing: An increasingly important step in managing hypertrophic cardiomyopathy.
2021 Magri, Damiano; Gallo, Giovanna
Cardiometabolic phenotype of heart failure with preserved ejection fraction as a target of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide receptor agonists
2021 Volpe, Massimo; Gallo, Giovanna
Insights from cardiopulmonary exercise testing in pediatric patients with hypertrophic cardiomyopathy
2021 Gallo, Giovanna; Mastromarino, Vittoria; Limongelli, Giuseppe; Calcagni, Giulio; Maruotti, Antonello; Ragni, Luca; Valente, Fabio; Musumeci, Maria Beatrice; Adorisio, Rachele; Rubino, Marta; Autore, Camillo; Magrì, Damiano
Sacubitril/Valsartan as a therapeutic tool across the range of Heart Failure phenotypes and ejection fraction spectrum
2021 Gallo, Giovanna; Volpe, Massimo; Battistoni, Allegra; Russo, Domitilla; Tocci, Giuliano; Musumeci, Maria Beatrice
Are post-hoc analyses on subgroups sufficient to support new treatment algorithms of heart failure? The case of SGLT2 inhibitors associated with sacubitril/valsartan
2021 Volpe, Massimo; Gallo, Giovanna; Zieroth, Shelley
A Contemporary View of Natriuretic Peptides in the SARS-CoV-2 Era
2021 Rubattu, S.; Gallo, G.; Volpe, M.
Targeting cyclic guanylate monophosphate in resistant hypertension and heart failure. Are sacubitril/valsartan and vericiguat synergistic and effective in both conditions?
2021 Gallo, G.; Rubattu, S.; Volpe, M.
Usefulness of the corporate wellness projects in primary prevention at the population level: a study on the prevalence, awareness, and control of hypertension in the Ferrari company
2021 Biffi, A.; Gallo, G.; Fernando, F.; Sirico, F.; Signorello, M. G.; Messina, M.; Manole, G.; Triglione, N.; Volpe, M.
Novel ANP (Atrial Natriuretic Peptide) based therapy for hypertension: the promising role of a disease mechanism targeted approach
2021 Volpe, Massimo; Gallo, Giovanna; Rubattu, Speranza
A Plea for Smoking-Free Policies in COVID-19 Times: Cardiovascular Prevention as an Ally in Coronavirus Containment
2021 Tini, Giacomo; Gallo, Giovanna; Musumeci, Beatrice; Tocci, Giuliano; Volpe, Massimo
[Prevention Italy 2021 - An update of the 2018 Consensus document and recommendations for the prevention of cardiovascular disease in Italy]
2021 Battistoni, Allegra; Gallo, Giovanna; Aragona, Caterina Oriana; Barchiesi, Fabio; Basolo, Alessio; Bellone, Simonetta; Bellotti, Paolo; Bertolotti, Marco; Bianco, Andrea; Biffi, Alessandro; Borghi, Claudio; Cicero, Arrigo Francesco Giuseppe; Consoli, Agostino; Corsini, Alberto; Desideri, Giovambattista; Di Giacinto, Barbara; Fernando, Fredrik; Ferri, Claudio; Galiuto, Leonarda; Grassi, Davide; Grassi, Guido; Icardi, Giancarlo; Indolfi, Ciro; Lodi, Elisa; Modena, Maria Grazia; Muiesan, Maria Lorenza; Nati, Giulio; Orsi, Andrea; Palermi, Stefano; Parati, Gianfranco; Passantino, Andrea; Patelli, Alessandra; Pelliccia, Antonio; Pengo, Martino; Filardi, Pasquale Perrone; Perseghin, Gianluca; Pirro, Matteo; Pontremoli, Roberto; Rengo, Giuseppe; Ricotti, Roberta; Rizzoni, Damiano; Rocca, Bianca; Rotella, Carlo; Rubattu, Speranza; Salvetti, Guido; Sciacqua, Angela; Serdoz, Andrea; Sirico, Felice; Squeo, Maria Rosaria; Tocci, Giuliano; Trimarco, Bruno; Vigili de Kreutzenberg, Saula; Volpe, Roberto; Volpe, Massimo
ARB-based combination therapy for the clinical management of hypertension and hypertension-related comorbidities: a spotlight on their use in COVID-19 patients
2021 Presta, Vivianne; Figliuzzi, Ilaria; Citoni, Barbara; Gallo, Giovanna; Battistoni, Allegra; Tocci, Giuliano; Volpe, Massimo
Sacubitril/valsartan for heart failure with preserved ejection fraction and resistant hypertension. one shot for a double strike?
2021 Volpe, Massimo; Gallo, Giovanna
Features and follow-up of patients affected by noninflammatory myocarditis after coronavirus disease 2019 vaccination
2022 Corradetti, Sara; Sclafani, Matteo; Mistrulli, Raffaella; Gallo, Giovanna; Pagannone, Erika; Di Girolamo, Marco; Autore, Camillo; Battistoni, Allegra; Volpe, Massimo
The natriuretic peptides for hypertension treatment
2022 Rubattu, S.; Gallo, G.
Updated Recommendations on Cardiovascular Prevention in 2022. An Executive Document of the Italian Society of Cardiovascular Prevention
2022 Volpe, Massimo; Gallo, Giovanna; Modena, Maria Grazia; Ferri, Claudio; Desideri, Giovambattista; Tocci, Giuliano
Old and new equations for maximal heart rate prediction in patients with heart failure and reduced ejection fraction on beta-blockers treatment: results from the MECKI score data set
2022 Magrì, Damiano; Piepoli, Massimo; Gallo, Giovanna; Corrà, Ugo; Metra, Marco; Paolillo, Stefania; Filardi, Pasquale Perrone; Maruotti, Antonello; Salvioni, Elisabetta; Mapelli, Massimo; Vignati, Carlo; Senni, Michele; Limongelli, Giuseppe; Lagioia, Rocco; Scrutinio, Domenico; Emdin, Michele; Passino, Claudio; Parati, Gianfranco; Sinagra, Gianfranco; Correale, Michele; Badagliacca, Roberto; Sciomer, Susanna; Di Lenarda, Andrea; Agostoni, Piergiuseppe
Angiotensin Receptor Blockers in the Management of Hypertension: A Real-World Perspective and Current Recommendations
2022 Gallo, Giovanna; Volpe, Massimo; Rubattu, Speranza
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Systolic blood pressure target less than 120 mmHg. the 'Chariot Allegory' in hypertension? | 2020 | Gallo, Giovanna; Volpe, Massimo | |
| A plea for smoking-free policies in COVID-19 times: cardiovascular prevention as an ally in coronavirus containment | 2021 | Tini, G.; Gallo, G.; Musumeci, B.; Tocci, G.; Volpe, M. | |
| Cardiopulmonary exercise testing: An increasingly important step in managing hypertrophic cardiomyopathy. | 2021 | Magri, Damiano; Gallo, Giovanna | |
| Cardiometabolic phenotype of heart failure with preserved ejection fraction as a target of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide receptor agonists | 2021 | Volpe, Massimo; Gallo, Giovanna | |
| Insights from cardiopulmonary exercise testing in pediatric patients with hypertrophic cardiomyopathy | 2021 | Gallo, Giovanna; Mastromarino, Vittoria; Limongelli, Giuseppe; Calcagni, Giulio; Maruotti, Antonello; Ragni, Luca; Valente, Fabio; Musumeci, Maria Beatrice; Adorisio, Rachele; Rubino, Marta; Autore, Camillo; Magrì, Damiano | |
| Sacubitril/Valsartan as a therapeutic tool across the range of Heart Failure phenotypes and ejection fraction spectrum | 2021 | Gallo, Giovanna; Volpe, Massimo; Battistoni, Allegra; Russo, Domitilla; Tocci, Giuliano; Musumeci, Maria Beatrice | |
| Are post-hoc analyses on subgroups sufficient to support new treatment algorithms of heart failure? The case of SGLT2 inhibitors associated with sacubitril/valsartan | 2021 | Volpe, Massimo; Gallo, Giovanna; Zieroth, Shelley | |
| A Contemporary View of Natriuretic Peptides in the SARS-CoV-2 Era | 2021 | Rubattu, S.; Gallo, G.; Volpe, M. | |
| Targeting cyclic guanylate monophosphate in resistant hypertension and heart failure. Are sacubitril/valsartan and vericiguat synergistic and effective in both conditions? | 2021 | Gallo, G.; Rubattu, S.; Volpe, M. | |
| Usefulness of the corporate wellness projects in primary prevention at the population level: a study on the prevalence, awareness, and control of hypertension in the Ferrari company | 2021 | Biffi, A.; Gallo, G.; Fernando, F.; Sirico, F.; Signorello, M. G.; Messina, M.; Manole, G.; Triglione, N.; Volpe, M. | |
| Novel ANP (Atrial Natriuretic Peptide) based therapy for hypertension: the promising role of a disease mechanism targeted approach | 2021 | Volpe, Massimo; Gallo, Giovanna; Rubattu, Speranza | |
| A Plea for Smoking-Free Policies in COVID-19 Times: Cardiovascular Prevention as an Ally in Coronavirus Containment | 2021 | Tini, Giacomo; Gallo, Giovanna; Musumeci, Beatrice; Tocci, Giuliano; Volpe, Massimo | |
| [Prevention Italy 2021 - An update of the 2018 Consensus document and recommendations for the prevention of cardiovascular disease in Italy] | 2021 | Battistoni, Allegra; Gallo, Giovanna; Aragona, Caterina Oriana; Barchiesi, Fabio; Basolo, Alessio; Bellone, Simonetta; Bellotti, Paolo; Bertolotti, Marco; Bianco, Andrea; Biffi, Alessandro; Borghi, Claudio; Cicero, Arrigo Francesco Giuseppe; Consoli, Agostino; Corsini, Alberto; Desideri, Giovambattista; Di Giacinto, Barbara; Fernando, Fredrik; Ferri, Claudio; Galiuto, Leonarda; Grassi, Davide; Grassi, Guido; Icardi, Giancarlo; Indolfi, Ciro; Lodi, Elisa; Modena, Maria Grazia; Muiesan, Maria Lorenza; Nati, Giulio; Orsi, Andrea; Palermi, Stefano; Parati, Gianfranco; Passantino, Andrea; Patelli, Alessandra; Pelliccia, Antonio; Pengo, Martino; Filardi, Pasquale Perrone; Perseghin, Gianluca; Pirro, Matteo; Pontremoli, Roberto; Rengo, Giuseppe; Ricotti, Roberta; Rizzoni, Damiano; Rocca, Bianca; Rotella, Carlo; Rubattu, Speranza; Salvetti, Guido; Sciacqua, Angela; Serdoz, Andrea; Sirico, Felice; Squeo, Maria Rosaria; Tocci, Giuliano; Trimarco, Bruno; Vigili de Kreutzenberg, Saula; Volpe, Roberto; Volpe, Massimo | |
| ARB-based combination therapy for the clinical management of hypertension and hypertension-related comorbidities: a spotlight on their use in COVID-19 patients | 2021 | Presta, Vivianne; Figliuzzi, Ilaria; Citoni, Barbara; Gallo, Giovanna; Battistoni, Allegra; Tocci, Giuliano; Volpe, Massimo | |
| Sacubitril/valsartan for heart failure with preserved ejection fraction and resistant hypertension. one shot for a double strike? | 2021 | Volpe, Massimo; Gallo, Giovanna | |
| Features and follow-up of patients affected by noninflammatory myocarditis after coronavirus disease 2019 vaccination | 2022 | Corradetti, Sara; Sclafani, Matteo; Mistrulli, Raffaella; Gallo, Giovanna; Pagannone, Erika; Di Girolamo, Marco; Autore, Camillo; Battistoni, Allegra; Volpe, Massimo | |
| The natriuretic peptides for hypertension treatment | 2022 | Rubattu, S.; Gallo, G. | |
| Updated Recommendations on Cardiovascular Prevention in 2022. An Executive Document of the Italian Society of Cardiovascular Prevention | 2022 | Volpe, Massimo; Gallo, Giovanna; Modena, Maria Grazia; Ferri, Claudio; Desideri, Giovambattista; Tocci, Giuliano | |
| Old and new equations for maximal heart rate prediction in patients with heart failure and reduced ejection fraction on beta-blockers treatment: results from the MECKI score data set | 2022 | Magrì, Damiano; Piepoli, Massimo; Gallo, Giovanna; Corrà, Ugo; Metra, Marco; Paolillo, Stefania; Filardi, Pasquale Perrone; Maruotti, Antonello; Salvioni, Elisabetta; Mapelli, Massimo; Vignati, Carlo; Senni, Michele; Limongelli, Giuseppe; Lagioia, Rocco; Scrutinio, Domenico; Emdin, Michele; Passino, Claudio; Parati, Gianfranco; Sinagra, Gianfranco; Correale, Michele; Badagliacca, Roberto; Sciomer, Susanna; Di Lenarda, Andrea; Agostoni, Piergiuseppe | |
| Angiotensin Receptor Blockers in the Management of Hypertension: A Real-World Perspective and Current Recommendations | 2022 | Gallo, Giovanna; Volpe, Massimo; Rubattu, Speranza |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile